Neurology exam questions
3 exam-length papers covering every published domain for Neurology.
DHA NRO50113 papers · 520 Qs
What is riding on this exam
~AED 1,030
Exam fee, per attempt
Published by DHA. Paid again on every re-sit.
3
Attempts - in total
The cap is three across all UAE authorities, not three each.
60%
Pass mark
Pass or fail only. Your score is never released.
One failed attempt costs you the fee again, plus months of delay on your licence, your visa and your start date. This bank costs about a 4th of one exam fee.
Try two questions from this bank
Real questions from the bank - pick an answer to see the rationale and reference.
Q1Patient Safety and Quality in Neurological Care
A stroke team audits door-to-needle times, finds a median of 78 minutes, introduces pre-notification by ambulance and direct-to-CT transfer, and presents the improvement plan at a departmental meeting. Which step is required to complete the audit cycle?
Choose an answer to see the rationale.
Q2Neuro-Immunological and Demyelinating Disorders
A 29-year-old woman with relapsing-remitting multiple sclerosis asks how pregnancy will affect her disease. Which statement should form the basis of your counselling?
Choose an answer to see the rationale.
Not sure where you stand? Sit 25 of these questions free, timed at real exam pace, and see which domains you are weakest in.
Take the free mock exam →Liked those? The full bank has 520 questions at this standard - every one with a rationale and a reference.
Get the full bank - AED 289What's inside
- ✓3 full-length papers (~150 Q each)
- ✓520 questions, no overlap between papers
- ✓Four options, one unambiguous best answer
- ✓A full rationale on every question
- ✓A real guideline or textbook reference
- ✓Every sub-topic in the published blueprint
Exam route by authority
| Authority | Delivered by | Specialist title |
|---|---|---|
| DHA - Dubai | Prometric | Computer-based MCQ |
| DOH - Abu Dhabi | Pearson VUE | Computer-based MCQ |
| MOHAP - Northern Emirates | Prometric | Computer-based MCQ |
| SCFHS - Saudi Arabia | Prometric / Pearson | Computer-based MCQ |
| QCHP - Qatar | Prometric | Computer-based MCQ |
| NHRA - Bahrain | Prometric | Computer-based MCQ |
| OMSB - Oman | Prometric | MCQ then oral viva |
Assessment mode depends on your licence title as well as your profession. Confirm your own route on your Sheryan / TAMM eligibility notice.
What the Neurology exam covers
The published blueprint for this exam breaks into 13 domains and 260 testable sub-topics. Our bank covers every one of them - here is the full map, so you can see exactly what you are expected to know.
Cerebrovascular Disorders15% (official - DHA/SCFHS blueprint)20 topics
- Cerebrovascular anatomy: circle of Willis, perforator territories, watershed zones and vascular-territory syndromes
- Acute ischaemic stroke: NIHSS, ASPECTS scoring, time windows and code-stroke pathways
- IV thrombolysis with alteplase/tenecteplase: indications, absolute and relative contraindications, dosing, door-to-needle targets
- Mechanical thrombectomy: large-vessel occlusion selection, extended window imaging (DAWN/DEFUSE-3 criteria), perfusion mismatch
- Post-thrombolysis complications: symptomatic haemorrhagic transformation, angioedema, blood-pressure protocols
- TIA assessment, ABCD2 risk stratification, urgent secondary prevention and dual antiplatelet therapy (CHANCE/POINT)
- +14 more in the bank
Epilepsy and Paroxysmal Disorders15% (official - DHA/SCFHS blueprint)20 topics
- ILAE 2017 classification of seizure types and epilepsies; definition of epilepsy and of resolved epilepsy
- First unprovoked seizure: investigation, recurrence risk and when to start an antiseizure medication
- Focal epilepsies: temporal lobe (mesial temporal sclerosis), frontal, parietal and occipital semiology
- Idiopathic generalised epilepsies: juvenile myoclonic epilepsy, childhood/juvenile absence, GTCS on awakening
- Developmental and epileptic encephalopathies: West, Lennox-Gastaut, Dravet, Ohtahara syndromes
- Self-limited epilepsy with centrotemporal spikes and other benign childhood epilepsies
- +14 more in the bank
Cephalgia and Headache Disorders15% (official - DHA/SCFHS blueprint)20 topics
- ICHD-3 classification and the primary/secondary headache framework
- Red flags for secondary headache (SNNOOP10) and appropriate neuroimaging thresholds
- Migraine without aura, with aura, and diagnostic criteria; migraine phases (premonitory, aura, headache, postdrome)
- Migraine with brainstem aura, hemiplegic migraine (FHM1-3) and retinal migraine
- Acute migraine treatment: NSAIDs, triptans and contraindications, gepants, ditans, antiemetics; parenteral rescue protocols
- Migraine prophylaxis: beta-blockers, topiramate, valproate, amitriptyline, candesartan, flunarizine, onabotulinumtoxinA for chronic migraine
- +14 more in the bank
Neuromuscular Disorders7% (official - DHA/SCFHS blueprint)20 topics
- Localising the lesion: anterior horn cell vs root vs plexus vs nerve vs neuromuscular junction vs muscle
- Guillain-Barre syndrome and variants (AIDP, AMAN, AMSAN, Miller Fisher): albuminocytological dissociation, IVIG vs plasma exchange, respiratory monitoring with FVC/NIF
- CIDP and its variants: diagnostic criteria, first-line immunotherapy, distinction from MMN with conduction block and from paraproteinaemic neuropathy
- Diabetic neuropathies: distal symmetric polyneuropathy, autonomic neuropathy, radiculoplexus neuropathy (diabetic amyotrophy), mononeuropathies
- Other acquired polyneuropathies: B12/copper deficiency, alcohol, uraemic, hepatic, thyroid, HIV, leprosy, vasculitic (mononeuritis multiplex)
- Toxic and drug-induced neuropathies: chemotherapy (platinum, taxanes, vincristine), amiodarone, isoniazid, heavy metals
- +14 more in the bank
Neuro-Immunological and Demyelinating Disorders7% (official - DHA/SCFHS blueprint)20 topics
- Multiple sclerosis: 2017 McDonald criteria, dissemination in space and time, CSF oligoclonal bands and kappa free light chains
- Clinically isolated syndrome, radiologically isolated syndrome and the risk of conversion
- MS phenotypes: relapsing-remitting, secondary progressive, primary progressive; disability measurement with EDSS
- MS MRI: characteristic lesion locations (periventricular, juxtacortical, infratentorial, spinal cord), Dawson fingers, central vein sign, black holes
- Acute relapse management: high-dose corticosteroids, plasma exchange for steroid-refractory relapse, pseudo-relapse and Uhthoff phenomenon
- Disease-modifying therapies: interferons, glatiramer, teriflunomide, dimethyl fumarate, S1P modulators, natalizumab, anti-CD20, cladribine, alemtuzumab
- +14 more in the bank
Neuro-Infectious Disorders7% (official - DHA/SCFHS blueprint)20 topics
- Acute bacterial meningitis: empirical antibiotics by age and risk group, adjunctive dexamethasone, timing of CT before LP
- CSF interpretation: cell count, differential, protein, glucose ratio, lactate, xanthochromia, PCR and multiplex panels
- Meningococcal disease, pneumococcal meningitis, Listeria, and post-neurosurgical/shunt-related meningitis
- Viral (aseptic) meningitis: enterovirus, HSV-2, VZV, mumps, HIV seroconversion
- HSV-1 encephalitis: temporal lobe involvement, EEG PLEDs, urgent aciclovir, post-HSV NMDAR encephalitis
- Arboviral and endemic encephalitides: West Nile, Japanese encephalitis, dengue, rabies; relevance in Gulf and returning-traveller contexts
- +14 more in the bank
Movement Disorders7% (official - DHA/SCFHS blueprint)20 topics
- Phenomenology: distinguishing tremor, chorea, dystonia, myoclonus, tics, athetosis, ballism and ataxia
- Parkinson disease: MDS clinical diagnostic criteria, supportive and red-flag features, prodromal markers
- Levodopa therapy, motor fluctuations, wearing-off, on-off phenomena and dyskinesias; delayed-on and dose failure
- Dopamine agonists and impulse control disorders; MAO-B inhibitors, COMT inhibitors, amantadine, apomorphine, levodopa-carbidopa intestinal gel
- Deep brain stimulation: STN vs GPi target selection, candidate criteria, contraindications and complications
- Non-motor features of Parkinson disease: REM sleep behaviour disorder, constipation, hyposmia, orthostatic hypotension, psychosis (pimavanserin/quetiapine/clozapine), depression, dementia
- +14 more in the bank
Cognitive Disorders7% (official - DHA/SCFHS blueprint)20 topics
- Cognitive domains and bedside assessment: MMSE, MoCA, ACE-III, clock drawing; culturally and linguistically appropriate testing in the Gulf
- Delirium vs dementia vs depression: diagnostic distinction, precipitants, prevention bundles and management
- Mild cognitive impairment: subtypes, biomarkers and conversion risk
- Alzheimer disease: NIA-AA framework, amyloid/tau/neurodegeneration biomarkers, CSF Abeta42/tau, amyloid PET, plasma p-tau217
- Alzheimer treatment: cholinesterase inhibitors, memantine, anti-amyloid monoclonal antibodies (lecanemab, donanemab) and ARIA monitoring
- Dementia with Lewy bodies: fluctuating cognition, visual hallucinations, parkinsonism, REM sleep behaviour disorder, neuroleptic sensitivity, DaTscan/MIBG
- +14 more in the bank
Clinical Neurophysiology, Neuroanatomical Localization and Neuroimaging5% (official - DHA/SCFHS blueprint; localization/imaging content is examined throughout, per the Brazis 'Localization in Clinical Neurology' reference)20 topics
- Principles of localization: cortex vs subcortex vs brainstem vs cord vs root vs plexus vs nerve vs junction vs muscle
- Brainstem syndromes: Wallenberg, Weber, Millard-Gubler, Benedikt, medial medullary; crossed findings
- Spinal cord syndromes: complete transection, Brown-Sequard, central cord, anterior cord, posterior column, conus vs cauda equina
- Cranial nerve anatomy and lesions I-XII, including cavernous sinus, orbital apex and jugular foramen syndromes
- EEG basics: montages, normal awake and sleep rhythms, alpha/beta/theta/delta, normal variants that mimic epileptiform activity
- Interictal epileptiform discharges, focal vs generalised patterns, 3-Hz spike-and-wave, hypsarrhythmia, slow spike-and-wave
- +14 more in the bank
Neurology of Systemic Diseases (including Nutritional, Metabolic and Toxic)5% (official - DHA/SCFHS blueprint; footnoted as including nutrition, metabolic, etc.)20 topics
- Hepatic encephalopathy: grading, precipitants, ammonia, lactulose/rifaximin; acquired hepatocerebral degeneration
- Uraemic encephalopathy, dialysis disequilibrium syndrome and uraemic neuropathy
- Electrolyte disturbances: hyponatraemia and osmotic demyelination syndrome, hypernatraemia, calcium and magnesium disorders
- Endocrine neurology: thyroid (Hashimoto encephalopathy, thyrotoxic periodic paralysis, myopathy), parathyroid, adrenal, pituitary disease and apoplexy
- Diabetes: hypoglycaemic brain injury, hyperosmolar states, diabetic ketoacidosis with cerebral oedema, neuropathy and stroke risk
- Nutritional deficiencies: thiamine (Wernicke-Korsakoff, dry beriberi), B12 and subacute combined degeneration, folate, niacin (pellagra), vitamin E, pyridoxine excess and deficiency, copper deficiency after bariatric surgery
- +14 more in the bank
Neuro-oncology, Neuro-ophthalmology, Neuro-otology and Sleep Neurology~8% (est.; not a separate section in the official DHA/SCFHS blueprint - this content is assessed within the Cognitive, Movement, Systemic Diseases and Clinical Neurophysiology sections, but is commonly examined and must not be omitted)20 topics
- Primary brain tumours: WHO CNS5 classification, glioma IDH/1p19q status, glioblastoma, meningioma, CNS lymphoma
- Brain metastases: primary sources, imaging pattern, surgery vs stereotactic radiosurgery vs whole-brain radiotherapy
- Raised intracranial pressure and cerebral oedema: dexamethasone, mannitol/hypertonic saline, herniation syndromes
- Tumour-related epilepsy, peri-operative seizure prophylaxis and antiseizure drug interactions with chemotherapy
- Pituitary tumours, craniopharyngioma, acromegaly and visual field defects; spinal cord tumours and neoplastic cord compression
- Radiation necrosis vs tumour progression; pseudoprogression on MRI
- +14 more in the bank
Patient Safety and Quality in Neurological Care5% (official - DHA/SCFHS blueprint; reference: SCFHS 'Essentials of Patient Safety')20 topics
- Patient safety terminology: adverse event, near miss, sentinel/never event, active failure vs latent condition
- Swiss cheese model, human factors and systems thinking applied to neurological error
- Incident reporting, root cause analysis, failure mode and effects analysis (FMEA) and just culture
- Medication safety in neurology: look-alike/sound-alike antiseizure drugs, high-alert drugs (anticoagulants, thrombolytics, IV valproate/phenytoin), infusion errors
- Thrombolysis safety: eligibility double-check, blood pressure limits, dosing errors, post-thrombolysis monitoring protocols
- Anticoagulation stewardship, bridging, reversal pathways and periprocedural management
- +14 more in the bank
Professionalism, Ethics and Communication5% (official - DHA/SCFHS blueprint; reference: SCFHS 'Professionalism and Ethics, Handbook for Residents')20 topics
- Core bioethical principles: autonomy, beneficence, non-maleficence, justice, and their application to neurological cases
- Informed consent: elements, documentation, consent for lumbar puncture, thrombolysis, EEG telemetry, research participation
- Capacity and competence assessment in cognitive impairment, aphasia and acute confusional states
- Surrogate decision-making, next-of-kin hierarchy and best-interest determinations in the UAE/GCC legal context
- Advance directives, do-not-resuscitate orders and withdrawal or withholding of life-sustaining treatment
- Brain death determination: ethical, legal and religious dimensions; family communication and organ donation discussions
- +14 more in the bank
Before you book your exam
Neurology licensing in the GCC
Requirements, timelines and salary by country
Do I need to sit a Prometric exam?
Check the format and pass mark for your authority
Am I eligible to apply?
Free eligibility check against the PQR criteria
Licensing in the UAE
DHA, DOH and MOHAP compared
Exam preparation support
One-to-one guidance alongside the question banks
Guides and articles
Dataflow, PCC, exam booking and relocation
Frequently asked questions
No. Every item is original, written by our team against the exam blueprint published by the health authorities. Real, recalled or leaked exam content breaches the testing bodies' rules and can lead to a permanent exam ban - we do not sell it, and neither should anyone else.
Still unsure whether you even need this exam?
Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.